Cardiovasc Res. 2023 Mar 21. pii: cvad044. [Epub ahead of print]
Kang Li,
Bin Li,
Dihua Zhang,
Tailai Du,
Huimin Zhou,
Gang Dai,
Youchen Yan,
Nailin Gao,
Xiaodong Zhuang,
Xinxue Liao,
Chen Liu,
Yugang Dong,
Demeng Chen,
Liang-Hu Qu,
Jingsong Ou,
Jian-Hua Yang,
Zhan-Peng Huang.
AIMS: The plasticity of vascular smooth muscle cells (VSMCs) enables them to alter phenotypes under various physiological and pathological stimuli. The alteration of VSMC phenotype is a key step in vascular diseases, including atherosclerosis. Although the transcriptome shift during VSMC phenotype alteration has been intensively investigated, uncovering multiple key regulatory signaling pathways, the translatome dynamics in this cellular process remain largely unknown. Here, we explored the genome-wide regulation at the translational level of human VSMCs during phenotype alteration.
METHODS AND RESULTS: We generated nucleotide-resolution translatome and transcriptome data from human VSMCs undergoing phenotype alteration. Deep sequencing of ribosome-protected fragments (Ribo-seq) revealed alterations in protein synthesis independent of changes in mRNA levels. Increased translational efficiency of many translational machinery components, including ribosomal proteins, eukaryotic translation elongation factors and initiation factors, were observed during the phenotype alteration of VSMCs. In addition, hundreds of candidates for short ORF-encoded polypeptides (SEPs), a class of peptides containing 200 aa or less, were identified in a combined analysis of translatome and transcriptome data with a high positive rate in validating their coding capability. Three evolutionarily conserved SEPs were further detected endogenously by customized antibodies and suggested to participate in the pathogenesis of atherosclerosis by analyzing the transcriptome and single cell RNA-seq data from patient atherosclerotic artery samples. Gain- and loss-of-function studies in human VSMCs and genetically engineered mice showed that these SEPs modulate the alteration of VSMC phenotype through different signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway and p53 pathway.
CONCLUSION: Our study indicates that an increase in the capacity of translation, which is attributable to an increased quantity of translational machinery components, mainly controls alterations of VSMC phenotype at the level of translational regulation. In addition, SEPs could function as important regulators in the phenotype alteration of human VSMCs.
TRANSLATIONAL PERSPECTIVE: Alterations of VSMC status are tightly associated with vascular diseases, including atherosclerosis. By incorporating Ribo-seq and RNA-seq of human VSMCs, we revealed that the increased translational capacity dominated the translational regulation of gene expression during alterations of VSMC phenotype. This finding of regulation in the translational level could provide new strategies of treating vascular diseases in the future. In addition, novel short ORF-encoded polypeptide (SEP) regulators for phenotype alteration were identified in the incorporated analyses. With the uncovered mechanisms, these SEPs may represent a new type of potential therapeutic target for clinical intervention of vascular diseases.
Keywords: Phenotype alteration; Ribo-seq; Translational landscape; Vascular smooth muscle cell; short ORF-encoded polypeptide